Molecules ranolazine to trastuzumab emtansine
100 molecules with a full cross-agency decision record, part of 534 published in total.
| Molecule | Decisions | Agencies | Class |
|---|---|---|---|
| ranolazine | 9 | 5 | Cardiac therapy |
| ravulizumab | 54 | 15 | Immunosuppressants |
| regorafenib | 30 | 12 | Antineoplastics |
| relugolix | 17 | 10 | Endocrine therapy |
| remimazolam | 9 | 6 | Psycholeptics |
| ribavirin | 7 | 3 | Antivirals |
| ribociclib | 50 | 14 | Antineoplastics |
| rifaximin | 9 | 5 | Antidiarrheals / intestinal anti-inflammatories |
| rilpivirine | 17 | 7 | Antivirals |
| riluzole | 7 | 4 | Other nervous system |
| rimegepant | 19 | 10 | Analgesics |
| ripretinib | 16 | 12 | Antineoplastics |
| risankizumab | 56 | 14 | Immunosuppressants |
| risperidone | 22 | 7 | Psycholeptics |
| ritlecitinib | 12 | 10 | Immunosuppressants |
| rituximab | 94 | 9 | Antineoplastics |
| rivaroxaban | 55 | 11 | Antithrombotics |
| roflumilast | 7 | 5 | Obstructive airway diseases |
| romiplostim | 19 | 9 | Antihemorrhagics |
| romosozumab | 20 | 13 | Bone diseases |
| rosuvastatin | 23 | 6 | Lipid modifying agents |
| rotigotine | 13 | 4 | Anti-parkinson |
| roxadustat | 11 | 11 | Antianemics |
| rozanolixizumab | 12 | 10 | Immunosuppressants |
| rucaparib | 17 | 9 | Antineoplastics |
| rufinamide | 13 | 7 | Antiepileptics |
| ruxolitinib | 50 | 12 | Antineoplastics |
| sacituzumab govitecan | 31 | 15 | Antineoplastics |
| sacubitril / valsartan | 12 | 9 | Renin-angiotensin system |
| salbutamol | 15 | 6 | Obstructive airway diseases |
| sapropterin | 23 | 11 | Other alimentary tract and metabolism |
| sarilumab | 16 | 10 | Immunosuppressants |
| satralizumab | 11 | 10 | Immunosuppressants |
| saxagliptin | 20 | 7 | Diabetes |
| sebelipase alfa | 9 | 8 | Other alimentary tract and metabolism |
| secukinumab | 79 | 12 | Immunosuppressants |
| selexipag | 12 | 8 | Antithrombotics |
| selinexor | 22 | 11 | Antineoplastics |
| selpercatinib | 53 | 13 | Antineoplastics |
| selumetinib | 18 | 14 | Antineoplastics |
| semaglutide | 53 | 14 | Diabetes |
| setmelanotide | 23 | 10 | Antiobesity preparations |
| sevelamer | 19 | 7 | Other therapeutic products |
| siltuximab | 8 | 6 | Immunosuppressants |
| simeprevir | 8 | 5 | Antivirals |
| siponimod | 14 | 12 | Immunosuppressants |
| sirolimus | 25 | 8 | Immunosuppressants |
| sitagliptin | 29 | 7 | Diabetes |
| sofosbuvir | 29 | 11 | Antivirals |
| sofosbuvir / velpatasvir | 18 | 9 | Antivirals |
| solifenacin | 12 | 5 | Urologicals |
| solriamfetol | 13 | 8 | Psychoanaleptics |
| somapacitan | 13 | 8 | Pituitary and hypothalamic hormones |
| somatrogon | 11 | 11 | Pituitary and hypothalamic hormones |
| somatropin | 51 | 9 | Pituitary and hypothalamic hormones |
| sonidegib | 9 | 7 | Antineoplastics |
| sorafenib | 18 | 8 | Antineoplastics |
| sotatercept | 13 | 12 | Antihypertensives |
| sotorasib | 18 | 12 | Antineoplastics |
| spesolimab | 15 | 9 | Immunosuppressants |
| sunitinib | 17 | 9 | Antineoplastics |
| tacrolimus | 34 | 8 | Immunosuppressants |
| tadalafil | 27 | 7 | Urologicals |
| tafamidis | 28 | 16 | Other nervous system |
| tafasitamab | 16 | 12 | Antineoplastics |
| tagraxofusp | 7 | 6 | Antineoplastics |
| talazoparib | 25 | 13 | Antineoplastics |
| talquetamab | 7 | 6 | Antineoplastics |
| tarlatamab | 10 | 7 | Antineoplastics |
| tebentafusp | 14 | 12 | Antineoplastics |
| teclistamab | 17 | 12 | Antineoplastics |
| teduglutide | 25 | 12 | Other alimentary tract and metabolism |
| telmisartan | 8 | 5 | Renin-angiotensin system |
| tenofovir | 23 | 4 | Antivirals |
| tenofovir disoproxil | 19 | 4 | Antivirals |
| tepotinib | 11 | 10 | Antineoplastics |
| teriflunomide | 18 | 10 | Immunosuppressants |
| teriparatide | 27 | 8 | Calcium homeostasis |
| testosterone | 15 | 6 | Sex hormones and modulators |
| tezepelumab | 24 | 13 | Obstructive airway diseases |
| thalidomide | 8 | 5 | Immunosuppressants |
| ticagrelor | 20 | 9 | Antithrombotics |
| tildrakizumab | 17 | 10 | Immunosuppressants |
| tipiracil / trifluridine | 22 | 9 | Ophthalmologicals |
| tirzepatide | 24 | 12 | Diabetes |
| tisagenlecleucel | 37 | 12 | Antineoplastics |
| tislelizumab | 48 | 12 | Antineoplastics |
| tivozanib | 8 | 8 | Antineoplastics |
| tocilizumab | 76 | 12 | Immunosuppressants |
| tofacitinib | 60 | 13 | Immunosuppressants |
| tolvaptan | 21 | 12 | Diuretics |
| topotecan | 17 | 7 | Antineoplastics |
| toripalimab | 11 | 8 | Antineoplastics |
| trabectedin | 14 | 6 | Antineoplastics |
| tralokinumab | 13 | 9 | Other dermatologicals |
| tramadol | 25 | 4 | Analgesics |
| trametinib | 18 | 8 | Antineoplastics |
| trastuzumab | 57 | 9 | Antineoplastics |
| trastuzumab deruxtecan | 64 | 14 | Antineoplastics |
| trastuzumab emtansine | 20 | 12 | Antineoplastics |